Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 2,200 shares of Masimo Corp. stock in a transaction dated Monday, October 3rd. The shares were sold at an average price of $60.00, for a total transaction of $132,000.00. Following the sale, the chief executive officer now owns 121,441 shares in the company, valued at $7,286,460. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.
Masimo Corp. (NASDAQ:MASI) opened at 59.97 on Monday. Masimo Corp. has a one year low of $33.03 and a one year high of $60.52. The company has a market capitalization of $2.96 billion, a P/E ratio of 31.45 and a beta of 0.70. The company’s 50-day moving average is $59.11 and its 200 day moving average is $51.48.
Masimo Corp. (NASDAQ:MASI) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.16. The company had revenue of $172.64 million for the quarter, compared to analyst estimates of $166.02 million. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. The company’s revenue was up 10.9% on a year-over-year basis. During the same period in the prior year, the firm earned $0.36 earnings per share. Analysts predict that Masimo Corp. will post $2.02 EPS for the current year.
Several institutional investors have recently modified their holdings of MASI. Nomura Holdings Inc. bought a new position in shares of Masimo Corp. during the second quarter valued at $286,000. Mason Street Advisors LLC acquired a new position in Masimo Corp. during the second quarter valued at approximately $453,000. Schwab Charles Investment Management Inc. increased its position in Masimo Corp. by 1.9% in the second quarter. Schwab Charles Investment Management Inc. now owns 194,923 shares of the company’s stock valued at $10,237,000 after buying an additional 3,586 shares during the period. Hillsdale Investment Management Inc. increased its position in Masimo Corp. by 16.0% in the second quarter. Hillsdale Investment Management Inc. now owns 10,900 shares of the company’s stock valued at $572,000 after buying an additional 1,500 shares during the period. Finally, Amalgamated Bank acquired a new position in Masimo Corp. during the second quarter valued at approximately $276,000. 79.88% of the stock is currently owned by institutional investors.
MASI has been the topic of several recent research reports. Wedbush reiterated an “outperform” rating and set a $63.00 target price (up from $60.00) on shares of Masimo Corp. in a research report on Thursday, August 4th. BTIG Research reiterated a “hold” rating on shares of Masimo Corp. in a research report on Friday, August 5th. Piper Jaffray Cos. reiterated an “overweight” rating and set a $55.00 target price (up from $52.00) on shares of Masimo Corp. in a research report on Friday, August 5th. Finally, Zacks Investment Research lowered shares of Masimo Corp. from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 4th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $52.60.
Masimo Corp. Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.